Audit 20383

FY End
2022-12-31
Total Expended
$1.33M
Findings
0
Programs
2
Organization: Addgene, Inc. (MA)
Year: 2022 Accepted: 2023-08-02

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $1.28M Yes 0
93.242 Mental Health Research Grants $59,002 Yes 0

Contacts

Name Title Type
NJKHH48EZVF3 Anne Donnelly Auditee
6172334363 Cecilia Frerotte Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The enclosed Schedule of Expenditures of Federal Awards includes all of Addgene Inc.s federal grant transaction activities recorded on an accrual accounting basis. The SEFA information only presents federal award activities and it does not include additional information, such as cash flow or net position. The SEFA information is presented in accordance with Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards (the Uniform Guidance) De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. Addgene utilized its approved indirect cost rate of 50%, not the 10% de minimis cost rate described in Section 200.414 of Uniform Guidance. Addgenes indirect cost rate is negotiated with the Department of Health and Human Services and it is applicable to all programs.